{"id":"https://genegraph.clinicalgenome.org/r/f2c532d1-c0f3-4a47-b0ba-479f8d593df7v1.0","type":"EvidenceStrengthAssertion","dc:description":"RYR1 was reported in relation to autosomal recessive RYR1-related myopathy in 2002 (Ferreiro et al., PMID:12112081). At least 14 unique variants (missense, frameshift, nonsense, splice) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 7 probands in 4 publications (PMIDs: 12112081, 12136074, 12719381, 18253926). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) and experimental evidence (6 pts) has been reached. Of note, this gene has also been implicated in autosomal dominant malignant hyperthermia and autosomal dominant RYR1-related myopathy. These will be assessed separately. This gene-disease association is supported by expression studies and animal models. In summary, RYR1 is definitively associated with autosomal recessive RYR1-related myopathy.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f2c532d1-c0f3-4a47-b0ba-479f8d593df7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10031","date":"2020-07-27T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10031","date":"2020-09-16T19:23:38.521Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f994694-02ac-4526-b608-45c333bf144f","type":"EvidenceLine","dc:description":"Downgraded due to morpholino and because exact replication of human phenotype was not demonstrated","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47f9d956-d265-4786-9bf9-df30e42fa05c","type":"Finding","dc:description":"This model provides a mechanism of how mutations in RYR1 affect muscle excitation-contraction coupling and cores were also seen in the zebrafish model similar to disease in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17596281","rdfs:label":"Zebra Fish Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/de355055-68df-493c-a65c-5932fde97356","type":"EvidenceLine","dc:description":"Downgraded because does not match human phenotype exactly.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b5e747d-a757-4908-b63e-be34bea7e709","type":"Finding","dc:description":"Both mice and humans exhibit muscle weakness and reduced RYR1 levels in muscle tissue. Both also have structural alterations in muscle fibers but the exact structural abnormalities vary and are heterogenous in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31044239","rdfs:label":"Knock In Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1fac63bb-b351-4882-b396-468ef36bf615","type":"EvidenceLine","dc:description":"Downgraded because no evidence of cores","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47cb6c3c-09b5-4b88-bff1-029a01e1b419","type":"Finding","dc:description":"Mouse mimics severe phenotype seen in recessive RYR1-related myopathies\nEarly–onset muscle weakness/hypotrophy, premature death","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31107960","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10fc9f1f-09a9-44c9-914a-5a60f65a3aaa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee451250-ca19-4edf-9fd0-65f45ac9e927","type":"Finding","dc:description":"Patient with severe form of MmD identified with compound hetorzygous RYR1 variants - R2939K and R2241X. Muscle biopsy at 30 yo shows increased fiber size variability and increase in internal nuclei in ~25% of fibres; predominance of hypotrophic type 1 fibers, core-like structures of various sizes with oxidative enzyme stains. Reduced expression of the protein also shown in tissue (this evidence was scored).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20080402","rdfs:label":"Immunofluorescence labeling","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc61edc9-f746-46c4-9953-10f07d518a05","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8368818-cb6b-4988-8da1-b23eb504cd6b","type":"Finding","dc:description":"Western blot analysis of RYR1 in controls shows relevant expression in skeletal muscle tissue","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Western Blot","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5e38905a-1306-4ead-a751-c47320c2c9ac","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97dd5597-f55d-4d00-b08c-4541cc1477f6","type":"Finding","dc:description":"Altered expression (reduced) in patients with at least one null biallelic mutation in RYR1","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Western Blot","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/514eb27e-dbcb-4af6-8997-1ffffb8d4af2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3e4019b-cbb3-4e25-86fc-afc4cfbcbbc5","type":"Finding","dc:description":"RYR1 expression shown in skeletal muscle tissue with immunofluorescence","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20080402","rdfs:label":"Immunofluorescence labeling","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/d5e4ff9a-94ad-453f-b2de-76deb98fe4ca_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c9a9f18-203f-4c37-b684-99b5999a7361_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/619073cc-9149-4fdb-a739-fc672412c00f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Male proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"detectionMethod":"Genomic DNA first screened for mutations in last 15 exons of RYR1 (CTD), RNA from muscle specimen then reverse transcribed and sequenced, haplotyping using microsatellite markers","firstTestingMethod":"Genotyping","phenotypeFreeText":"Cores devoid of oxidative activity in skeletal muscle, variable number and size of fibers, type 1 fiber predominance, greater cores with age","phenotypes":["obo:HP_0001319","obo:HP_0001270","obo:HP_0001943","obo:HP_0004887","obo:HP_0001371","obo:HP_0003324","obo:HP_0002540","obo:HP_0003202","obo:HP_0002751","obo:HP_0008180"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2c9a9f18-203f-4c37-b684-99b5999a7361_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","allele":[{"id":"https://genegraph.clinicalgenome.org/r/dbc736ac-4e5d-4d6a-9c2d-72702589b3c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.3(RYR1):c.14545G>A (p.Val4849Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024171"}},{"id":"https://genegraph.clinicalgenome.org/r/71d1edad-c521-4145-9d5e-3d07a973be15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001042723.2(RYR1):c.1739_1742dup (p.His581fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024307"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c55e50a4-fb49-487c-a1a9-68d137cf5a67_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Kept at 2 full points because linkage analysis was performed","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/722857c5-df6b-43e3-908c-71d7ecf669b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12719381","rdfs:label":"Monnier 2003 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Haplotyping and linkage analysis identified common RYR1 haplotype shared by both parents – LOD score: 1.19\nDirect sequencing of all overlapping fragments of RYR1 cDNA from biopsy","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"thorax deformity, eccentric cores associated with mini cores, abnormal fiber size variability, centrally located nuclei, core lesions, localized sarcomere disorganization & mitochondria depletion","phenotypes":["obo:HP_0001999","obo:HP_0003457","obo:HP_0002650","obo:HP_0003324","obo:HP_0001270","obo:HP_0001319","obo:HP_0003202","obo:HP_0002540","obo:HP_0002093"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c55e50a4-fb49-487c-a1a9-68d137cf5a67_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12719381","allele":{"id":"https://genegraph.clinicalgenome.org/r/24abdbe2-2247-4d2c-97de-6a7afaebb959","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.14647-1449A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024206"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/afba2dfc-ab34-432d-a310-afb4ffda3495_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9007aa2-84c7-48ac-99ee-fc769f2eb98c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Case 6 (Patient II:1)","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"detectionMethod":"Genomic DNA first screened for mutations in last 15 exons of RYR1 (CTD), RNA from muscle specimen then reverse transcribed and sequenced, haplotyping using microsatellite markers","firstTestingMethod":"Genotyping","phenotypeFreeText":"distal hyperlaxity, Cores devoid of oxidative activity in skeletal muscle, variable number and size of fibers, type 1 fiber predominance, greater cores with age","phenotypes":["obo:HP_0002093","obo:HP_0001319","obo:HP_0001349","obo:HP_0003307","obo:HP_0003202","obo:HP_0003324","obo:HP_0002808","obo:HP_0002205","obo:HP_0001488","obo:HP_0002015"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/afba2dfc-ab34-432d-a310-afb4ffda3495_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","allele":[{"id":"https://genegraph.clinicalgenome.org/r/3653a185-3fae-4c63-99a2-e1db56c64ce6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.5938del (p.Leu1980fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024545"}},{"id":"https://genegraph.clinicalgenome.org/r/08dd92df-3dca-4277-afe7-828c36f2dcac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.3(RYR1):c.11315G>A (p.Arg3772Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA023909"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bfbb35b5-78be-4fb6-8b02-3598367df9ba_proband_score_evidence_line","type":"EvidenceLine","dc:description":"not scored because missense variant was shown in other study to not have pathogenic effect","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72c10da5-d817-4c1b-97e5-09cdf09ed507","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Female proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"detectionMethod":"Genomic DNA first screened for mutations in last 15 exons of RYR1 (CTD), RNA from muscle specimen then reverse transcribed and sequenced, haplotyping using microsatellite markers","firstTestingMethod":"Genotyping","phenotypeFreeText":"Cores devoid of oxidative activity in skeletal muscle, variable number and size of fibers, type 1 fiber predominance, greater cores with age","phenotypes":["obo:HP_0002719","obo:HP_0004887","obo:HP_0002015","obo:HP_0003324","obo:HP_0001371","obo:HP_0002093","obo:HP_0001319","obo:HP_0003202","obo:HP_0002751","obo:HP_0000602"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bfbb35b5-78be-4fb6-8b02-3598367df9ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a60a6a30-5745-461a-9cad-21f5b68640db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.7324-1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024767"}},{"id":"https://genegraph.clinicalgenome.org/r/037a47bc-c96b-49dd-bb74-0f0f2b6997c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.14524G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024165"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8047d72c-0773-4691-a04f-cf1a8c0a1ca3_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2327272f-bbd0-420e-966a-f37aae31369a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Case 10","ageType":"AgeAtReport","ageUnit":"Years","ageValue":39,"detectionMethod":"Genomic DNA first screened for mutations in last 15 exons of RYR1 (CTD), RNA from muscle specimen then reverse transcribed and sequenced, haplotyping using microsatellite markers","firstTestingMethod":"Genotyping","phenotypeFreeText":"Cores devoid of oxidative activity in skeletal muscle, variable number and size of fibers, type 1 fiber predominance, greater cores with age","phenotypes":["obo:HP_0003691","obo:HP_0001761","obo:HP_0000602","obo:HP_0001324","obo:HP_0002650","obo:HP_0008180","obo:HP_0001270"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8047d72c-0773-4691-a04f-cf1a8c0a1ca3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","allele":[{"id":"https://genegraph.clinicalgenome.org/r/045dd3d0-d3b5-4cac-a006-e44fc045dbda","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.4934G>A (p.Arg1645Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024471"}},{"id":"https://genegraph.clinicalgenome.org/r/b8856fb7-e641-4079-87dd-874174a15d62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.7261G>C (p.Ala2421Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024730"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/279c39a0-ecc0-4dc5-bcad-4448565d8ff1_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/775a4fda-6c95-4559-a275-d7dd0210b619","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Case 9","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"detectionMethod":"Genomic DNA first screened for mutations in last 15 exons of RYR1 (CTD), RNA from muscle specimen then reverse transcribed and sequenced, haplotyping using microsatellite markers","firstTestingMethod":"Genotyping","phenotypeFreeText":"Cores devoid of oxidative activity in skeletal muscle, variable number and size of fibers, type 1 fiber predominance, greater cores with age","phenotypes":["obo:HP_0003202","obo:HP_0001324","obo:HP_0001319"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/279c39a0-ecc0-4dc5-bcad-4448565d8ff1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","allele":[{"id":"https://genegraph.clinicalgenome.org/r/6d50eac8-60d3-46fe-9e30-127e9fe9cc14","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.3(RYR1):c.12800_12801dup (p.Ala4268ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532380"}},{"id":"https://genegraph.clinicalgenome.org/r/8d2c7368-9211-4376-8dab-eb92974be69f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.5110G>A (p.Gly1704Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024481"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d716b94f-f3b0-4c87-afe4-62e31d081c8d_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10ef5caf-811a-49f9-8fec-30f8bbae2608","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","rdfs:label":"Case 8","ageType":"AgeAtReport","ageUnit":"Years","ageValue":48,"detectionMethod":"Genomic DNA first screened for mutations in last 15 exons of RYR1 (CTD), RNA from muscle specimen then reverse transcribed and sequenced, haplotyping using microsatellite markers","firstTestingMethod":"Genotyping","phenotypeFreeText":"moderate slowly progressive muscle weakness, Cores devoid of oxidative activity in skeletal muscle, variable number and size of fibers, type 1 fiber predominance, biopsy indicated mini cores evolved into wide cores","phenotypes":["obo:HP_0001270","obo:HP_0003202","obo:HP_0001349","obo:HP_0008180"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d716b94f-f3b0-4c87-afe4-62e31d081c8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18253926","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ffa2272f-ee94-4638-92f7-70632ed078b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.13691G>A (p.Arg4564Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA080956"}},{"id":"https://genegraph.clinicalgenome.org/r/bb803ecb-7421-426b-847a-bbc9d05a3b76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.2455C>T (p.Arg819Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA024351"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/17be437a-7abe-4faa-a3f8-5ebf0d925371_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Scored default 0.5 points for a missense variant with functional evidence of pathogenicity","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/663a2d40-d26a-4903-b410-eecd3c871415","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12112081","rdfs:label":"Ferreiro Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Used 280 microsatellite markers, Linkage analysis, RYR1 direct sequencing","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"proximal, axial & hand muscle weakness, mild heel joint contractures, joint hyperlaxity scoliosis, Type 1 fiber uniformity, small zones of Z-disk streaming on EM, long core lesions in few spared fibers","phenotypes":["obo:HP_0001319","obo:HP_0030237","obo:HP_0001270"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/17be437a-7abe-4faa-a3f8-5ebf0d925371_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12112081","allele":{"id":"https://genegraph.clinicalgenome.org/r/60c29635-5c44-40ca-bdc6-540f05ec08e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000540.2(RYR1):c.10579C>T (p.Pro3527Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA023845"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":1147,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/sAjx3kYCe_Q","type":"GeneValidityProposition","disease":"obo:MONDO_0100150","gene":"hgnc:10483","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d5e4ff9a-94ad-453f-b2de-76deb98fe4ca-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}